ARTICLE | Company News
CardioVascular BioTherapeutics, Cardio Neo-Genesis L.P. deal
November 24, 2008 8:00 AM UTC
CardioVascular will receive up to $15 million from Cardio Neo-Genesis to fund clinical development of CardioVascular's CVBT-141H to treat coronary heart disease (CHD). In return, Cardio Neo-Genesis is...